Status:
RECRUITING
Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers
Lead Sponsor:
CHU de Reims
Conditions:
Urinary Bladder Tumour
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate the performance of vibrational spectroscopy (Infrared and Raman spectroscopy techniques) in bladder cancer diagnosis using urine samples.
Detailed Description
Urologic cancers affect the organs and structures of the male and female urinary tract and the male reproductive system. Bladder cancer (BCa) is the second urological cancer in incidence after prostat...
Eligibility Criteria
Inclusion
- inclusion criteria:
- Must be over 18 years of age
- Able to give consent and understand the purpose the study
- Agree to participate in the study and having signed the non-objection document
- Admitted to a urology consultation for cystoscopy
- exclusion criteria: Patients with any of the following criteria will not be included in the study
- Refused to participate in the study or unable to give consent
- without a native bladder
- with a bladder fistula
Exclusion
Key Trial Info
Start Date :
March 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 6 2026
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT06087016
Start Date
March 6 2023
End Date
March 6 2026
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France